← FDA Drug Approvals (Drugs@FDA)

POSACONAZOLE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ASPIRO · Approved 2024-12-23

Drug application

FDA Application #

ANDA219057

Application type

Abbreviated New Drug Application (Generic)

Brand name

POSACONAZOLE

Generic name

POSACONAZOLE

Active ingredients

POSACONAZOLE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

ASPIRO

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2024-12-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown